Super Spectra.jpg
Yevgeny-Beiderman-Super-Spectra.jpg
Yevgeny Beiderman
CEO

Super Specta develops electro-optic device for Alzheimer’s disease (AD) early detection & deterioration follow-up, by real-time imaging of AD’s Bio-markers at the CerebroSpinal Fluid (CSF).

 

This is the only known non-invasive direct CSF analysis, and is Ionizing radiation free, pain free and risk free. Therefore, tests can be performed daily \ weekly, for frequent patient monitoring.

Along with AD, the system has the potential to monitor other degenerative brain diseases

stripBIG-01.jpg

PORTFOLIO

 
icon-08.png

DEVICES

icon-09.png
icon-07.png

PHARMA & BIOTECH

icon-10.png
icon-06.png

PHARMA & BIOTECH

icon-11.png